n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ESPERARE-FOUNDATION

More Like This

Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders

PR Newswire associated0

Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.

Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress

Business Wire logo

EveryONE Medicines and Mendelian Partner to Transform UK Landscape for Rare Disease Diagnosis and Personalized Treatment

Rare Diseases: Collaboration is key. image: AdobeStock_1308212316

AOP Health on Rare Diseases: Information. Collaboration. Innovation.

PR Newswire associated0

Norgine strengthens rare disease portfolio with acquisition of Theravia

LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children

PR Newswire associated0

Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies